查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2032 年神經血管設備市場——按產品、按工藝、按治療應用、按最終用途和全球預測
市場調查報告書
商品編碼
1257999

2023-2032 年神經血管設備市場——按產品、按工藝、按治療應用、按最終用途和全球預測

Neurovascular Devices Market - By Product, By Process, By Therapeutic Applications, By End-use & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 462 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於神經血管設備的不斷創新，預計從 2023 年到 2032 年，神經血管設備市場將出現顯著增長。

近年來，神經技術通過閉環治療控制系統更有效地發展，以最佳空間分辨率提供刺激以獲得更好的臨床結果。

預計市場巨頭持續推出的產品和營銷策略將影響未來幾年的整體商業環境。 例如，2022 年，美敦力公司宣布推出美敦力神經血管合作實驗室平台，該平台旨在推動中風治療和護理領域的創新。

神經血管設備行業按產品、工藝、治療應用、最終用途和地理區域進行細分。

在產品的基礎上，神經血栓切除術設備領域將從 2023 年到 2032 年獲得發展勢頭。 該細分市場的增長可歸因於全球急性缺血性中風發病率的增加。 據世界衛生組織統計，全球每年約有1500萬人可能患中風。 神經血栓切除術也已成為急性缺血性中風最優選的治療方法之一，因為它提供了更好的結果並降低了患者死亡率。

考慮到這一過程，預計神經血栓切除術領域在 2023 年至 2032 年期間的複合年增長率將超過 6%。 增強神經血栓切除術的產品進步將在預測期內推動該細分市場的增長。

在治療應用方面，狹窄領域在 2022 年的價值超過 5.67 億美元。 顱內狹窄支持腦動脈變窄。 預計到 2032 年，椎管狹窄發病率的增加將積極推動節段擴張。 例如，多項使用國際疾病分類代碼的研究表明，2022 年椎管狹窄的患病率在 7% 到 23% 之間。

到 2032 年，最終用戶預計診所的複合年增長率將超過 6%。 這一細分市場的擴張可歸因於越來越多的患者湧入診所治療神經血管疾病，如動脈瘤和出血性中風，以及尋求具有成本效益的初級保健。 此外，一些診所引進了最先進的神經血管設備，這將推動市場發展。

按地區劃分，2022 年歐洲神經血管器械市場將佔據 29.5% 以上的市場份額。 該地區的市場增長將來自德國、英國和法國等國家日益增加的慢性神經系統疾病負擔。 根據一項研究，神經系統疾病在歐盟排名第三，僅次於 CVD 和癌症，2020 年的患病率超過 13%。 此外，整個行業都將受益於該地區行業領先參與者的存在。

內容

第一章調查方法及範圍

第 2 章執行摘要

第 3 章：神經血管設備的行業洞察

  • 行業格局，2018-2032 年版
  • 影響行業的因素
    • 司機
      • 北美腦動脈瘤和缺血性中風的增加
      • 對微創手術的需求不斷增長
      • 神經血管治療技術進展
      • 政府為實現全球醫療保健基礎設施現代化所做的努力
    • 行業潛在的風險和挑戰
      • 需要設計更有效、更便宜的治療方法
      • 新興經濟體中與神經血管設備商業化相關的挑戰
  • 增長分析
    • 按產品分類
    • 按流程
    • 通過治療用途
    • 按最終用途
  • COVID-19 影響分析
  • 技術概況
  • 供應鏈分析
  • 監管和贖回狀態
  • 波特分析
  • PESTEL 分析

第四章競爭格局

  • 介紹
  • 公司矩陣分析
  • 2021 年創新領導者競爭分析
    • 強生公司
    • 美敦力
    • 史賽克
    • 泰爾茂公司
  • 戰略儀表板
  • 競爭對手定位矩陣
  • 戰略視角矩陣

第 5 章神經血管設備市場：按產品分類

  • 主要產品趨勢
  • 栓塞線圈
  • 頸動脈支架
  • 顱內支架
  • 導管
  • 栓塞保護裝置
  • 分流器
  • 神經取栓裝置
  • 內環裝置
  • 氣球系統
  • 支架回收器
  • 導絲
  • 其他

第 6 章神經血管設備市場：按流程

  • 主要流程趨勢
  • 神經血栓切除術
  • 腦血管造影
  • 頸動脈內膜切除術 (CEA)
  • 支架植入術
  • 顯微手術夾閉
  • 捲繞
  • 流量潛水員
  • 其他

第 7 章神經血管設備市場：按治療用途分類

  • 主要治療應用的趨勢
  • 腦動脈瘤
  • 狹窄
  • 缺血性中風
  • 其他

第 8 章神經血管設備市場：按最終用途分類

  • 主要的最終用戶趨勢
  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第 9 章神經血管設備市場：按地區

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 土耳其人
    • 荷蘭
    • 比利時
    • 奧地利
    • 瑞士
    • 波蘭
    • 捷克共和國
    • 匈牙利
    • 葡萄牙
    • 希臘
    • 羅馬尼亞
    • 保加利亞
    • 丹麥
    • 瑞典
    • 挪威
    • 芬蘭
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 新加坡
    • 香港
    • 台灣
    • 印度尼西亞
    • 柬埔寨
    • 菲律賓
    • 越南
    • 馬來西亞
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 沙特阿拉伯
    • 南非
    • 阿聯酋

第十章公司簡介

  • Asahi Intecc CO., LTD.
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Medix Corp.
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation
簡介目錄
Product Code: 794

Neurovascular Devices Market is anticipated to depict strong growth during 2023-2032, owing to the constant technological innovations across neurovascular devices. In recent times, neurotechnologies have evolved to be more effective with closed-loop therapeutic control systems that deliver stimulation with optimal spatial resolution for better clinical outcomes.

Ongoing product launches and marketing strategies by leading market behemoths is speculated to influence the overall business landscape through the coming years. For instance, Medtronic plc in 2022, launched Medtronic Neurovascular Co-Lab Platform developed to expedite the innovation in stroke treatment and care.

Overall, the neurovascular devices industry is segmented in terms of product, process, therapeutic application, end-use, and region.

Based on the product, the neurothrombectomy devices segment will gain momentum from 2023 to 2032. The segmental growth will be attributed to the rising incidences of acute ischemic stroke globally. As per the WHO statistics, approximately 15 million people are likely to suffer from stroke each year globally. In addition, the neurothrombectomy procedure offers better outcomes and lowers the mortality rate in patients making it one of the most preferred treatments for acute ischemic stroke.

Considering the process, the neurothrombectomy procedure segment will depict over 6% CAGR between 2023-2032. Increasing product advancements offering enhanced neurothrombectomy procedures will favor segmental growth over the forecast period.

By therapeutic application, the stenosis segment was valued at over USD 567 million in 2022. Intracranial stenosis supports narrowing of a brain artery. Increasing incidences of spinal stenosis will positively stimulate segment expansion by 2032. For instance, several studies using the International Classification of Diseases codes revealed that the prevalence of spinal stenosis was between 7% and 23% in 2022.

In terms of end-user, the clinics segment is slated to exhibit over 6% CAGR through 2032. The segmental expansion would be ascribed to the growing patient influx in clinics for neurovascular illness treatments such as aneurysms and hemorrhagic strokes and cost-effective primary care. Also, several clinics are being outfitted with cutting-edge neurovascular equipment, which will fuel the market development.

Regionally, Europe neurovascular devices market held over 29.5% market share in 2022. The regional market growth would come from the rising burden of chronic neurological disorders across countries such as Germany, the UK, and France. As per a study, neurological disorders in the EU ranked third after CVDs and cancers depicting more than 13% prevalence in 2020. In addition, the presence of the leading industry participants across the region will benefit the overall industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope and definitions
  • 1.3 Base estimates and working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Neurovascular devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Process trends
    • 2.1.4 Therapeutic application trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Neurovascular Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of brain aneurysm and ischemic strokes in North America
      • 3.2.1.2 Rising demand for minimally invasive surgical procedures
      • 3.2.1.3 Technological advancement in neurovascular treatments
      • 3.2.1.4 Government initiatives to modernize healthcare infrastructure across the globe
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Need for designing more effective and low-cost treatments
      • 3.2.2.2 Challenges involved in commercialization of neurovascular devices across developing and underdeveloped economies
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By process
    • 3.3.3 By therapeutic application
    • 3.3.4 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Technology landscape
  • 3.6 Supply chain analysis
  • 3.7 Regulatory and reimbursement landscape
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of innovation leaders, 2021
    • 4.3.1 Johnson & Johnson Inc
    • 4.3.2 Medtronic
    • 4.3.3 Stryker
    • 4.3.4 Terumo Corporation
  • 4.4 Strategy dashboard
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic outlook matrix

Chapter 5 Neurovascular Devices Market, By Product

  • 5.1 Key product trends
  • 5.2 Embolic coils
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.3 Carotid stents
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.4 Intracranial stents
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.5 Catheters
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.6 Embolic protection devices
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.7 Flow diverters
    • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.8 Neurothrombectomy devices
    • 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.8.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.9 Intrasaccular devices
    • 5.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.9.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.10 Balloon systems
    • 5.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.10.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.11 Stent retrievers
    • 5.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.11.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.12 Guidewires
    • 5.12.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.12.2 Market estimates and forecast, 2018 - 2032 (000' Units)
  • 5.13 Others
    • 5.13.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.13.2 Market estimates and forecast, 2018 - 2032 (000' Units)

Chapter 6 Neurovascular Devices Market, By Process

  • 6.1 Key process trends
  • 6.2 Neurothrombectomy procedure
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Cerebral angiography technique
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Carotid endarterectomy (CEA)
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 Stenting
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.6 Microsurgical clipping
    • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.7 Coiling
    • 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.8 Flow diversion
    • 6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.9 Others
    • 6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Neurovascular Devices Market, By Therapeutic Application

  • 7.1 Key therapeutic application trends
  • 7.2 Brain aneurysm
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Stenosis
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4 Ischemic stroke
    • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5 Others
    • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Neurovascular Devices Market, By End-use

  • 8.1 Key end-use trends
  • 8.2 Hospitals
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Ambulatory surgical centers
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Clinics
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Others
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Neurovascular Devices Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 UK
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Russia
    • 9.3.7 Turkey
    • 9.3.8 Netherlands
    • 9.3.9 Belgium
    • 9.3.10 Austria
    • 9.3.11 Switzerland
    • 9.3.12 Poland
    • 9.3.13 Czech Republic
    • 9.3.14 Hungary
    • 9.3.15 Portugal
    • 9.3.16 Greece
    • 9.3.17 Romania
    • 9.3.18 Bulgaria
    • 9.3.19 Denmark
    • 9.3.20 Sweden
    • 9.3.21 Norway
    • 9.3.22 Finland
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Singapore,
    • 9.4.7 Hong Kong
    • 9.4.8 Taiwan,
    • 9.4.9 Indonesia
    • 9.4.10 Cambodia
    • 9.4.11 Philippines
    • 9.4.12 Vietnam,
    • 9.4.13 Malaysia
    • 9.4.14 Thailand
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 MEA
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Asahi Intecc CO., LTD.
  • 10.2 Integer Holdings Corporation
  • 10.3 Johnson & Johnson Services, Inc.
  • 10.4 Kaneka Medix Corp.
  • 10.5 LivaNova PLC
  • 10.6 Medtronic
  • 10.7 MicroPort Scientific Corporation
  • 10.8 Penumbra, Inc.
  • 10.9 Stryker
  • 10.10 Terumo Corporation